技术资料
-
文献Fang L et al. (MAY 2008) The Journal of Experimental Medicine 205 5 1037--48
Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation
We identify the tumor necrosis factor receptor superfamily 25 (TNFRSF25)/TNFSF15 pair as critical trigger for allergic lung inflammation,which is a cardinal feature of asthma. TNFRSF25 (TNFR25) signals are required to exert T helper cell 2 (Th2) effector function in Th2-polarized CD4 cells and co-stimulate interleukin (IL)-13 production by glycosphingolipid-activated NKT cells. In vivo,antibody blockade of TNFSF15 (TL1A),which is the ligand for TNFR25,inhibits lung inflammation and production of Th2 cytokines such as IL-13,even when administered days after airway antigen exposure. Similarly,blockade of TNFR25 by a dominant-negative (DN) transgene,DN TNFR25,confers resistance to lung inflammation in mice. Allergic lung inflammation-resistant,NKT-deficient mice become susceptible upon adoptive transfer of wild-type NKT cells,but not after transfer of DN TNFR25 transgenic NKT cells. The TNFR25/TL1A pair appears to provide an early signal for Th2 cytokine production in the lung,and therefore may be a drug target in attempts to attenuate lung inflammation in asthmatics. View Publication -
文献Maes C et al. (MAY 2006) The Journal of clinical investigation 116 5 1230--42
Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair.
Current therapies for delayed- or nonunion bone fractures are still largely ineffective. Previous studies indicated that the VEGF homolog placental growth factor (PlGF) has a more significant role in disease than in health. Therefore we investigated the role of PlGF in a model of semi-stabilized bone fracture healing. Fracture repair in mice lacking PlGF was impaired and characterized by a massive accumulation of cartilage in the callus,reminiscent of delayed- or nonunion fractures. PlGF was required for the early recruitment of inflammatory cells and the vascularization of the fracture wound. Interestingly,however,PlGF also played a role in the subsequent stages of the repair process. Indeed in vivo and in vitro findings indicated that PlGF induced the proliferation and osteogenic differentiation of mesenchymal progenitors and stimulated cartilage turnover by particular MMPs. Later in the process,PlGF was required for the remodeling of the newly formed bone by stimulating osteoclast differentiation. As PlGF expression was increased throughout the process of bone repair and all the important cell types involved expressed its receptor VEGFR-1,the present data suggest that PlGF is required for mediating and coordinating the key aspects of fracture repair. Therefore PlGF may potentially offer therapeutic advantages for fracture repair. View Publication -
文献Vieillard V et al. (AUG 2005) Proceedings of the National Academy of Sciences 102 31 10981--86
NK cytotoxicity against CD4+ T cells during HIV-1 infection: A gp41 peptide induces the expression of an NKp44 ligand
HIV infection leads to a state of chronic immune activation and progressive deterioration in immune function,manifested most recognizably by the progressive depletion of CD4+ T cells. A substantial percentage of natural killer (NK) cells from patients with HIV infection are activated and express the natural cytotoxicity receptor (NCR) NKp44. Here we show that a cellular ligand for NKp44 (NKp44L) is expressed during HIV-1 infection and is correlated with both the progression of CD4+ T cell depletion and the increase of viral load. CD4+ T cells expressing this ligand are highly sensitive to the NK lysis activity mediated by NKp44+ NK cells. The expression of NKp44L is induced by the linear motif NH2-SWSNKS-COOH of the HIV-1 envelope gp41 protein. This highly conserved motif appears critical to the sharp increase in NK lysis of CD4+ T cells from HIV-infected patients. These studies strongly suggest that induction of NKp44L plays a key role in the lysis of CD4+ T cells by activated NK cells in HIV infection and consequently provide a framework for considering how HIV-1 may use NK cell immune surveillance to trigger CD4+ T cells. Understanding this mechanism may help to develop future therapeutic strategies and vaccines against HIV-1 infection. View Publication -
文献Jones DC et al. (JUL 2003) Journal of immunology 171 1 196--203
Peroxisome proliferator-activated receptor alpha negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation.
Expression of the nuclear hormone receptor peroxisome proliferator-activated receptor alpha (PPARalpha) in resting lymphocytes was recently established,although the physiologic role(s) played by this nuclear hormone receptor in these cell types remains unresolved. In this study,we used CD4(+) T cells isolated from PPARalpha(-/-) and wild-type mice,as well as cell lines that constitutively express PPARalpha,in experiments designed to evaluate the role of this hormone receptor in the regulation of T cell function. We report that activated CD4(+) T cells lacking PPARalpha produce increased levels of IFN-gamma,but significantly lower levels of IL-2 when compared with activated wild-type CD4(+) T cells. Furthermore,we demonstrate that PPARalpha regulates the expression of these cytokines by CD4(+) T cells in part,through its ability to negatively regulate the transcription of T-bet. The induction of T-bet expression in CD4(+) T cells was determined to be positively influenced by p38 mitogen-activated protein (MAP) kinase activation,and the presence of unliganded PPARalpha effectively suppressed the phosphorylation of p38 MAP kinase. The activation of PPARalpha with highly specific ligands relaxed its capacity to suppress p38 MAP kinase phosphorylation and promoted T-bet expression. These results demonstrate a novel DNA-binding independent and agonist-controlled regulatory influence by the nuclear hormone receptor PPARalpha. View Publication
过滤器
筛选结果
类别
- 产品说明
Show More
Show Less
研究领域
- HIV 85 项目
- HLA 60 项目
- 上皮细胞研究 259 项目
- 代谢 4 项目
- 免疫 985 项目
- 内皮细胞研究 8 项目
- 呼吸系统研究 31 项目
- 嵌合体 30 项目
- 干细胞生物学 2865 项目
- 感染性疾病(传染病) 36 项目
- 抗体制备 5 项目
- 杂交瘤制备 20 项目
- 疾病建模 171 项目
- 癌症 688 项目
- 神经科学 643 项目
- 移植研究 102 项目
- 类器官 126 项目
- 细胞外囊泡研究 4 项目
- 细胞治疗开发 99 项目
- 细胞系制备 182 项目
- 脐带血库 70 项目
- 药物发现和毒理检测 348 项目
- 血管生成细胞研究 58 项目
Show More
Show Less
产品系列
- ClonaCell 3 项目
- EasySep 1 项目
- MethoCult 1 项目
Show More
Show Less
细胞类型
- B 细胞 224 项目
- CD4+ 141 项目
- CD8+ 109 项目
- CHO细胞 18 项目
- HUVEC细胞(人脐静脉内皮细胞) 1 项目
- NK 细胞 162 项目
- PSC衍生 177 项目
- T 细胞 465 项目
- 上皮细胞 121 项目
- 中胚层 22 项目
- 乳腺细胞 101 项目
- 先天性淋巴细胞 37 项目
- 全血 6 项目
- 其他子集 20 项目
- 其他细胞系 6 项目
- 内皮细胞 17 项目
- 内皮集落形成细胞(ECFCs) 3 项目
- 内胚层 20 项目
- 前列腺细胞 19 项目
- 多巴胺能神经元 5 项目
- 多能干细胞 1950 项目
- 小胶质细胞 3 项目
- 巨噬细胞 31 项目
- 巨核细胞 9 项目
- 心肌细胞 35 项目
- 成骨细胞 6 项目
- 星形胶质细胞 4 项目
- 杂交瘤细胞 96 项目
- 树突状细胞(DCs) 125 项目
- 气道细胞 84 项目
- 淋巴细胞 72 项目
- 癌细胞和细胞系 139 项目
- 白细胞 9 项目
- 白细胞单采样本 11 项目
- 白血病/淋巴瘤细胞 14 项目
- 监管 57 项目
- 真皮细胞 2 项目
- 神经元 182 项目
- 神经干/祖细胞 465 项目
- 神经细胞 112 项目
- 粒细胞及其亚群 100 项目
- 红系细胞 11 项目
- 红细胞 12 项目
- 肌源干/祖细胞 10 项目
- 肝细胞 36 项目
- 肠道细胞 75 项目
- 肾脏细胞 6 项目
- 肿瘤细胞 12 项目
- 胰腺细胞 16 项目
- 脂肪细胞 6 项目
- 脑肿瘤干细胞 97 项目
- 血小板 4 项目
- 血浆 15 项目
- 血管生成细胞 3 项目
- 调节性细胞 11 项目
- 软骨细胞 7 项目
- 造血干祖细胞 959 项目
- 造血细胞 23 项目
- 间充质基质细胞 14 项目
- 间充质干祖细胞 195 项目
- 间充质细胞 19 项目
- 骨髓基质细胞 2 项目
- 骨髓瘤细胞 5 项目
- 髓系细胞 142 项目
- 鼠胚胎成纤维细胞 1 项目
Show More
Show Less